This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Urethritis

Authoring team

Urethritis is inflammation of the urethra.

  • it is a multifactorial condition which is sexually acquired in the majority of cases (1)
  • in the UK, it is the most common condition diagnosed and treated in men attending genitourinary medicine (GUM) clinics with around 80,000 new cases each year (2)

The patient complains of pain and urethral discharge, and of dysuria but maybe asymptomatic in some patients (1).

  • among men, around 30-50% are asymptomatic while in women, this amount is higher
  • onset may be sudden or insidious (3)

The disease is confirmed by demonstrating an excess number of polymorpho nuclear leucocytes (PMNLs) in the anterior urethra (1).

The condition can be associated with complications including acute epididymitis, orchitis, and prostatitis (4).

Reference:

  1. Horner PJ et al. 2016 European guideline on the management of non-gonococcal urethritis. Int J STD AIDS. 2016;27(11):928-37
  2. Smith TJ. Urethritis in men. InnovAiT. 2013;6(2):83-87
  3. Hakenberg OW et al. Urethritis in men and women. European Urology Supplements. 2017;16:144-148
  4. Bachmann LH et al. Advances in understanding and treatment of male urethritis. Clinical Infectious Diseases. 2015;61(S8):S763

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.